Notice of Public Hearing
Pursuant to subsection E of § 54.1-3443, the Board of Pharmacy is giving notice of a public hearing to consider placement of chemical substances in Schedule I of the Drug Control Act and to consider removal of chemical substances in Schedule IV. The public hearing will be conducted at 9:05 a.m. on March 30, 2023. Instructions will be included in the agenda for the board meeting, also on March 30th. Public comment may also be submitted electronically or in writing prior to September 6th to Caroline Juran, Executive Director of the Board of Pharmacy to firstname.lastname@example.org.
Pursuant to article § 54.1-3443(E), the following drugs will be placed in Schedule I to conform with federal scheduling actions taken from July 7, 2022 to February 3, 2023:
Pursuant to article § 54.1-3443(E), the following drug will be removed from Schedule IV to conform with federal scheduling actions taken from July 7, 2022 to February 3, 2023:
|Name / Title:||Caroline Juran, RPh / Executive Director|
9960 Mayland Drive
|Telephone:||(804)367-4456 FAX: (804)527-4472 TDD: ()-|